Chronic Granulomatous Disease (CGD) is a rare genetic disorder that affects the immune system, specifically the ability of phagocytes to produce reactive oxygen species (ROS) necessary for ...

In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...

Consult a medical professional for advice. Source: Focus Medica Chronic granulomatous disease (CGD), also known as Bridges–Good syndrome, chronic granulomatous disorder, and Quie syndrome ...

Kostas Biliouris, an analyst from BMO Capital, maintained the Buy rating on Prime Medicine, Inc. (PRME – Research Report). The associated price ...